DOI · e01.org

Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells Technologies

Diana Aparecida Dias Câmara, Lisley I. Mambelli, Allan Saj Porcacchia, Irina Kerkis · Journal of Cancer · 2016

  • DOI 10.7150/jca.16629
  • Publisher Ivyspring International Publisher
  • Type review
  • Issued 2016

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · review · 2016

Abstract

Cancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved.Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor.Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells.These methods are quite complex, thus a simple and efficient method of reprogramming is still required.As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening.This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression.The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field.

Open the resolved locator · 10.7150/jca.16629

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:20 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v07p2296.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.